Request for Covid-19 Impact Assessment of this Report
The United States Human Rabies Immune Globulin (HRIG) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Human Rabies Immune Globulin (HRIG) market, reaching US$ million by the year 2028. As for the Europe Human Rabies Immune Globulin (HRIG) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Human Rabies Immune Globulin (HRIG) players cover CSL Behring, Grifols, Sanofi, and Sichuan Yuanda Shuyang, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Rabies Immune Globulin (HRIG) market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
200IU
500IU
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Category II Exposure
Category III Exposure
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
CSL Behring
Grifols
Sanofi
Sichuan Yuanda Shuyang
CNBG
Kamada
CBPO
Shuanglin Bio
Weiguang Bio
Shanghai RAAS
Bharat Serum
VINS
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Rabies Immune Globulin (HRIG) Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Human Rabies Immune Globulin (HRIG) by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Human Rabies Immune Globulin (HRIG) by Country/Region, 2017, 2022 & 2028
2.2 Human Rabies Immune Globulin (HRIG) Segment by Type
2.2.1 200IU
2.2.2 500IU
2.3 Human Rabies Immune Globulin (HRIG) Sales by Type
2.3.1 Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Type (2017-2022)
2.3.2 Global Human Rabies Immune Globulin (HRIG) Revenue and Market Share by Type (2017-2022)
2.3.3 Global Human Rabies Immune Globulin (HRIG) Sale Price by Type (2017-2022)
2.4 Human Rabies Immune Globulin (HRIG) Segment by Application
2.4.1 Category II Exposure
2.4.2 Category III Exposure
2.5 Human Rabies Immune Globulin (HRIG) Sales by Application
2.5.1 Global Human Rabies Immune Globulin (HRIG) Sale Market Share by Application (2017-2022)
2.5.2 Global Human Rabies Immune Globulin (HRIG) Revenue and Market Share by Application (2017-2022)
2.5.3 Global Human Rabies Immune Globulin (HRIG) Sale Price by Application (2017-2022)
3 Global Human Rabies Immune Globulin (HRIG) by Company
3.1 Global Human Rabies Immune Globulin (HRIG) Breakdown Data by Company
3.1.1 Global Human Rabies Immune Globulin (HRIG) Annual Sales by Company (2020-2022)
3.1.2 Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Company (2020-2022)
3.2 Global Human Rabies Immune Globulin (HRIG) Annual Revenue by Company (2020-2022)
3.2.1 Global Human Rabies Immune Globulin (HRIG) Revenue by Company (2020-2022)
3.2.2 Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Company (2020-2022)
3.3 Global Human Rabies Immune Globulin (HRIG) Sale Price by Company
3.4 Key Manufacturers Human Rabies Immune Globulin (HRIG) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Rabies Immune Globulin (HRIG) Product Location Distribution
3.4.2 Players Human Rabies Immune Globulin (HRIG) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Human Rabies Immune Globulin (HRIG) by Geographic Region
4.1 World Historic Human Rabies Immune Globulin (HRIG) Market Size by Geographic Region (2017-2022)
4.1.1 Global Human Rabies Immune Globulin (HRIG) Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Human Rabies Immune Globulin (HRIG) Annual Revenue by Geographic Region
4.2 World Historic Human Rabies Immune Globulin (HRIG) Market Size by Country/Region (2017-2022)
4.2.1 Global Human Rabies Immune Globulin (HRIG) Annual Sales by Country/Region (2017-2022)
4.2.2 Global Human Rabies Immune Globulin (HRIG) Annual Revenue by Country/Region
4.3 Americas Human Rabies Immune Globulin (HRIG) Sales Growth
4.4 APAC Human Rabies Immune Globulin (HRIG) Sales Growth
4.5 Europe Human Rabies Immune Globulin (HRIG) Sales Growth
4.6 Middle East & Africa Human Rabies Immune Globulin (HRIG) Sales Growth
5 Americas
5.1 Americas Human Rabies Immune Globulin (HRIG) Sales by Country
5.1.1 Americas Human Rabies Immune Globulin (HRIG) Sales by Country (2017-2022)
5.1.2 Americas Human Rabies Immune Globulin (HRIG) Revenue by Country (2017-2022)
5.2 Americas Human Rabies Immune Globulin (HRIG) Sales by Type
5.3 Americas Human Rabies Immune Globulin (HRIG) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Rabies Immune Globulin (HRIG) Sales by Region
6.1.1 APAC Human Rabies Immune Globulin (HRIG) Sales by Region (2017-2022)
6.1.2 APAC Human Rabies Immune Globulin (HRIG) Revenue by Region (2017-2022)
6.2 APAC Human Rabies Immune Globulin (HRIG) Sales by Type
6.3 APAC Human Rabies Immune Globulin (HRIG) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Human Rabies Immune Globulin (HRIG) by Country
7.1.1 Europe Human Rabies Immune Globulin (HRIG) Sales by Country (2017-2022)
7.1.2 Europe Human Rabies Immune Globulin (HRIG) Revenue by Country (2017-2022)
7.2 Europe Human Rabies Immune Globulin (HRIG) Sales by Type
7.3 Europe Human Rabies Immune Globulin (HRIG) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Human Rabies Immune Globulin (HRIG) by Country
8.1.1 Middle East & Africa Human Rabies Immune Globulin (HRIG) Sales by Country (2017-2022)
8.1.2 Middle East & Africa Human Rabies Immune Globulin (HRIG) Revenue by Country (2017-2022)
8.2 Middle East & Africa Human Rabies Immune Globulin (HRIG) Sales by Type
8.3 Middle East & Africa Human Rabies Immune Globulin (HRIG) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Rabies Immune Globulin (HRIG)
10.3 Manufacturing Process Analysis of Human Rabies Immune Globulin (HRIG)
10.4 Industry Chain Structure of Human Rabies Immune Globulin (HRIG)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Rabies Immune Globulin (HRIG) Distributors
11.3 Human Rabies Immune Globulin (HRIG) Customer
12 World Forecast Review for Human Rabies Immune Globulin (HRIG) by Geographic Region
12.1 Global Human Rabies Immune Globulin (HRIG) Market Size Forecast by Region
12.1.1 Global Human Rabies Immune Globulin (HRIG) Forecast by Region (2023-2028)
12.1.2 Global Human Rabies Immune Globulin (HRIG) Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Human Rabies Immune Globulin (HRIG) Forecast by Type
12.7 Global Human Rabies Immune Globulin (HRIG) Forecast by Application
13 Key Players Analysis
13.1 CSL Behring
13.1.1 CSL Behring Company Information
13.1.2 CSL Behring Human Rabies Immune Globulin (HRIG) Product Offered
13.1.3 CSL Behring Human Rabies Immune Globulin (HRIG) Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 CSL Behring Main Business Overview
13.1.5 CSL Behring Latest Developments
13.2 Grifols
13.2.1 Grifols Company Information
13.2.2 Grifols Human Rabies Immune Globulin (HRIG) Product Offered
13.2.3 Grifols Human Rabies Immune Globulin (HRIG) Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Grifols Main Business Overview
13.2.5 Grifols Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Human Rabies Immune Globulin (HRIG) Product Offered
13.3.3 Sanofi Human Rabies Immune Globulin (HRIG) Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Sichuan Yuanda Shuyang
13.4.1 Sichuan Yuanda Shuyang Company Information
13.4.2 Sichuan Yuanda Shuyang Human Rabies Immune Globulin (HRIG) Product Offered
13.4.3 Sichuan Yuanda Shuyang Human Rabies Immune Globulin (HRIG) Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Sichuan Yuanda Shuyang Main Business Overview
13.4.5 Sichuan Yuanda Shuyang Latest Developments
13.5 CNBG
13.5.1 CNBG Company Information
13.5.2 CNBG Human Rabies Immune Globulin (HRIG) Product Offered
13.5.3 CNBG Human Rabies Immune Globulin (HRIG) Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 CNBG Main Business Overview
13.5.5 CNBG Latest Developments
13.6 Kamada
13.6.1 Kamada Company Information
13.6.2 Kamada Human Rabies Immune Globulin (HRIG) Product Offered
13.6.3 Kamada Human Rabies Immune Globulin (HRIG) Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Kamada Main Business Overview
13.6.5 Kamada Latest Developments
13.7 CBPO
13.7.1 CBPO Company Information
13.7.2 CBPO Human Rabies Immune Globulin (HRIG) Product Offered
13.7.3 CBPO Human Rabies Immune Globulin (HRIG) Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 CBPO Main Business Overview
13.7.5 CBPO Latest Developments
13.8 Shuanglin Bio
13.8.1 Shuanglin Bio Company Information
13.8.2 Shuanglin Bio Human Rabies Immune Globulin (HRIG) Product Offered
13.8.3 Shuanglin Bio Human Rabies Immune Globulin (HRIG) Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Shuanglin Bio Main Business Overview
13.8.5 Shuanglin Bio Latest Developments
13.9 Weiguang Bio
13.9.1 Weiguang Bio Company Information
13.9.2 Weiguang Bio Human Rabies Immune Globulin (HRIG) Product Offered
13.9.3 Weiguang Bio Human Rabies Immune Globulin (HRIG) Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Weiguang Bio Main Business Overview
13.9.5 Weiguang Bio Latest Developments
13.10 Shanghai RAAS
13.10.1 Shanghai RAAS Company Information
13.10.2 Shanghai RAAS Human Rabies Immune Globulin (HRIG) Product Offered
13.10.3 Shanghai RAAS Human Rabies Immune Globulin (HRIG) Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Shanghai RAAS Main Business Overview
13.10.5 Shanghai RAAS Latest Developments
13.11 Bharat Serum
13.11.1 Bharat Serum Company Information
13.11.2 Bharat Serum Human Rabies Immune Globulin (HRIG) Product Offered
13.11.3 Bharat Serum Human Rabies Immune Globulin (HRIG) Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Bharat Serum Main Business Overview
13.11.5 Bharat Serum Latest Developments
13.12 VINS
13.12.1 VINS Company Information
13.12.2 VINS Human Rabies Immune Globulin (HRIG) Product Offered
13.12.3 VINS Human Rabies Immune Globulin (HRIG) Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 VINS Main Business Overview
13.12.5 VINS Latest Developments
14 Research Findings and Conclusion
Table 1. Human Rabies Immune Globulin (HRIG) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Human Rabies Immune Globulin (HRIG) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 200IU
Table 4. Major Players of 500IU
Table 5. Global Human Rabies Immune Globulin (HRIG) Sales by Type (2017-2022) & (K Units)
Table 6. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Type (2017-2022)
Table 7. Global Human Rabies Immune Globulin (HRIG) Revenue by Type (2017-2022) & ($ million)
Table 8. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Type (2017-2022)
Table 9. Global Human Rabies Immune Globulin (HRIG) Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Human Rabies Immune Globulin (HRIG) Sales by Application (2017-2022) & (K Units)
Table 11. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Application (2017-2022)
Table 12. Global Human Rabies Immune Globulin (HRIG) Revenue by Application (2017-2022)
Table 13. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Application (2017-2022)
Table 14. Global Human Rabies Immune Globulin (HRIG) Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Human Rabies Immune Globulin (HRIG) Sales by Company (2020-2022) & (K Units)
Table 16. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Company (2020-2022)
Table 17. Global Human Rabies Immune Globulin (HRIG) Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Company (2020-2022)
Table 19. Global Human Rabies Immune Globulin (HRIG) Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Human Rabies Immune Globulin (HRIG) Producing Area Distribution and Sales Area
Table 21. Players Human Rabies Immune Globulin (HRIG) Products Offered
Table 22. Human Rabies Immune Globulin (HRIG) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Human Rabies Immune Globulin (HRIG) Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Human Rabies Immune Globulin (HRIG) Sales Market Share Geographic Region (2017-2022)
Table 27. Global Human Rabies Immune Globulin (HRIG) Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Human Rabies Immune Globulin (HRIG) Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Country/Region (2017-2022)
Table 31. Global Human Rabies Immune Globulin (HRIG) Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Human Rabies Immune Globulin (HRIG) Sales by Country (2017-2022) & (K Units)
Table 34. Americas Human Rabies Immune Globulin (HRIG) Sales Market Share by Country (2017-2022)
Table 35. Americas Human Rabies Immune Globulin (HRIG) Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Human Rabies Immune Globulin (HRIG) Revenue Market Share by Country (2017-2022)
Table 37. Americas Human Rabies Immune Globulin (HRIG) Sales by Type (2017-2022) & (K Units)
Table 38. Americas Human Rabies Immune Globulin (HRIG) Sales Market Share by Type (2017-2022)
Table 39. Americas Human Rabies Immune Globulin (HRIG) Sales by Application (2017-2022) & (K Units)
Table 40. Americas Human Rabies Immune Globulin (HRIG) Sales Market Share by Application (2017-2022)
Table 41. APAC Human Rabies Immune Globulin (HRIG) Sales by Region (2017-2022) & (K Units)
Table 42. APAC Human Rabies Immune Globulin (HRIG) Sales Market Share by Region (2017-2022)
Table 43. APAC Human Rabies Immune Globulin (HRIG) Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Human Rabies Immune Globulin (HRIG) Revenue Market Share by Region (2017-2022)
Table 45. APAC Human Rabies Immune Globulin (HRIG) Sales by Type (2017-2022) & (K Units)
Table 46. APAC Human Rabies Immune Globulin (HRIG) Sales Market Share by Type (2017-2022)
Table 47. APAC Human Rabies Immune Globulin (HRIG) Sales by Application (2017-2022) & (K Units)
Table 48. APAC Human Rabies Immune Globulin (HRIG) Sales Market Share by Application (2017-2022)
Table 49. Europe Human Rabies Immune Globulin (HRIG) Sales by Country (2017-2022) & (K Units)
Table 50. Europe Human Rabies Immune Globulin (HRIG) Sales Market Share by Country (2017-2022)
Table 51. Europe Human Rabies Immune Globulin (HRIG) Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Human Rabies Immune Globulin (HRIG) Revenue Market Share by Country (2017-2022)
Table 53. Europe Human Rabies Immune Globulin (HRIG) Sales by Type (2017-2022) & (K Units)
Table 54. Europe Human Rabies Immune Globulin (HRIG) Sales Market Share by Type (2017-2022)
Table 55. Europe Human Rabies Immune Globulin (HRIG) Sales by Application (2017-2022) & (K Units)
Table 56. Europe Human Rabies Immune Globulin (HRIG) Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Human Rabies Immune Globulin (HRIG) Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Human Rabies Immune Globulin (HRIG) Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Human Rabies Immune Globulin (HRIG) Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Human Rabies Immune Globulin (HRIG) Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Human Rabies Immune Globulin (HRIG) Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Human Rabies Immune Globulin (HRIG) Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Human Rabies Immune Globulin (HRIG) Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Human Rabies Immune Globulin (HRIG) Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Human Rabies Immune Globulin (HRIG)
Table 66. Key Market Challenges & Risks of Human Rabies Immune Globulin (HRIG)
Table 67. Key Industry Trends of Human Rabies Immune Globulin (HRIG)
Table 68. Human Rabies Immune Globulin (HRIG) Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Human Rabies Immune Globulin (HRIG) Distributors List
Table 71. Human Rabies Immune Globulin (HRIG) Customer List
Table 72. Global Human Rabies Immune Globulin (HRIG) Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Human Rabies Immune Globulin (HRIG) Sales Market Forecast by Region
Table 74. Global Human Rabies Immune Globulin (HRIG) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Human Rabies Immune Globulin (HRIG) Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Human Rabies Immune Globulin (HRIG) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Human Rabies Immune Globulin (HRIG) Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Human Rabies Immune Globulin (HRIG) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Human Rabies Immune Globulin (HRIG) Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Human Rabies Immune Globulin (HRIG) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Human Rabies Immune Globulin (HRIG) Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Human Rabies Immune Globulin (HRIG) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Human Rabies Immune Globulin (HRIG) Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Human Rabies Immune Globulin (HRIG) Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Human Rabies Immune Globulin (HRIG) Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Human Rabies Immune Globulin (HRIG) Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Human Rabies Immune Globulin (HRIG) Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Human Rabies Immune Globulin (HRIG) Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share Forecast by Application (2023-2028)
Table 92. CSL Behring Basic Information, Human Rabies Immune Globulin (HRIG) Manufacturing Base, Sales Area and Its Competitors
Table 93. CSL Behring Human Rabies Immune Globulin (HRIG) Product Offered
Table 94. CSL Behring Human Rabies Immune Globulin (HRIG) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. CSL Behring Main Business
Table 96. CSL Behring Latest Developments
Table 97. Grifols Basic Information, Human Rabies Immune Globulin (HRIG) Manufacturing Base, Sales Area and Its Competitors
Table 98. Grifols Human Rabies Immune Globulin (HRIG) Product Offered
Table 99. Grifols Human Rabies Immune Globulin (HRIG) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Grifols Main Business
Table 101. Grifols Latest Developments
Table 102. Sanofi Basic Information, Human Rabies Immune Globulin (HRIG) Manufacturing Base, Sales Area and Its Competitors
Table 103. Sanofi Human Rabies Immune Globulin (HRIG) Product Offered
Table 104. Sanofi Human Rabies Immune Globulin (HRIG) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Sanofi Main Business
Table 106. Sanofi Latest Developments
Table 107. Sichuan Yuanda Shuyang Basic Information, Human Rabies Immune Globulin (HRIG) Manufacturing Base, Sales Area and Its Competitors
Table 108. Sichuan Yuanda Shuyang Human Rabies Immune Globulin (HRIG) Product Offered
Table 109. Sichuan Yuanda Shuyang Human Rabies Immune Globulin (HRIG) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Sichuan Yuanda Shuyang Main Business
Table 111. Sichuan Yuanda Shuyang Latest Developments
Table 112. CNBG Basic Information, Human Rabies Immune Globulin (HRIG) Manufacturing Base, Sales Area and Its Competitors
Table 113. CNBG Human Rabies Immune Globulin (HRIG) Product Offered
Table 114. CNBG Human Rabies Immune Globulin (HRIG) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. CNBG Main Business
Table 116. CNBG Latest Developments
Table 117. Kamada Basic Information, Human Rabies Immune Globulin (HRIG) Manufacturing Base, Sales Area and Its Competitors
Table 118. Kamada Human Rabies Immune Globulin (HRIG) Product Offered
Table 119. Kamada Human Rabies Immune Globulin (HRIG) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Kamada Main Business
Table 121. Kamada Latest Developments
Table 122. CBPO Basic Information, Human Rabies Immune Globulin (HRIG) Manufacturing Base, Sales Area and Its Competitors
Table 123. CBPO Human Rabies Immune Globulin (HRIG) Product Offered
Table 124. CBPO Human Rabies Immune Globulin (HRIG) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. CBPO Main Business
Table 126. CBPO Latest Developments
Table 127. Shuanglin Bio Basic Information, Human Rabies Immune Globulin (HRIG) Manufacturing Base, Sales Area and Its Competitors
Table 128. Shuanglin Bio Human Rabies Immune Globulin (HRIG) Product Offered
Table 129. Shuanglin Bio Human Rabies Immune Globulin (HRIG) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Shuanglin Bio Main Business
Table 131. Shuanglin Bio Latest Developments
Table 132. Weiguang Bio Basic Information, Human Rabies Immune Globulin (HRIG) Manufacturing Base, Sales Area and Its Competitors
Table 133. Weiguang Bio Human Rabies Immune Globulin (HRIG) Product Offered
Table 134. Weiguang Bio Human Rabies Immune Globulin (HRIG) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Weiguang Bio Main Business
Table 136. Weiguang Bio Latest Developments
Table 137. Shanghai RAAS Basic Information, Human Rabies Immune Globulin (HRIG) Manufacturing Base, Sales Area and Its Competitors
Table 138. Shanghai RAAS Human Rabies Immune Globulin (HRIG) Product Offered
Table 139. Shanghai RAAS Human Rabies Immune Globulin (HRIG) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Shanghai RAAS Main Business
Table 141. Shanghai RAAS Latest Developments
Table 142. Bharat Serum Basic Information, Human Rabies Immune Globulin (HRIG) Manufacturing Base, Sales Area and Its Competitors
Table 143. Bharat Serum Human Rabies Immune Globulin (HRIG) Product Offered
Table 144. Bharat Serum Human Rabies Immune Globulin (HRIG) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Bharat Serum Main Business
Table 146. Bharat Serum Latest Developments
Table 147. VINS Basic Information, Human Rabies Immune Globulin (HRIG) Manufacturing Base, Sales Area and Its Competitors
Table 148. VINS Human Rabies Immune Globulin (HRIG) Product Offered
Table 149. VINS Human Rabies Immune Globulin (HRIG) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. VINS Main Business
Table 151. VINS Latest Developments
List of Figures
Figure 1. Picture of Human Rabies Immune Globulin (HRIG)
Figure 2. Human Rabies Immune Globulin (HRIG) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Rabies Immune Globulin (HRIG) Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Human Rabies Immune Globulin (HRIG) Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Human Rabies Immune Globulin (HRIG) Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 200IU
Figure 10. Product Picture of 500IU
Figure 11. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Type in 2021
Figure 12. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Type (2017-2022)
Figure 13. Human Rabies Immune Globulin (HRIG) Consumed in Category II Exposure
Figure 14. Global Human Rabies Immune Globulin (HRIG) Market: Category II Exposure (2017-2022) & (K Units)
Figure 15. Human Rabies Immune Globulin (HRIG) Consumed in Category III Exposure
Figure 16. Global Human Rabies Immune Globulin (HRIG) Market: Category III Exposure (2017-2022) & (K Units)
Figure 17. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Application (2017-2022)
Figure 18. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Application in 2021
Figure 19. Human Rabies Immune Globulin (HRIG) Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Company in 2021
Figure 21. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Geographic Region in 2021
Figure 23. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Region (2017-2022)
Figure 24. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Country/Region in 2021
Figure 25. Americas Human Rabies Immune Globulin (HRIG) Sales 2017-2022 (K Units)
Figure 26. Americas Human Rabies Immune Globulin (HRIG) Revenue 2017-2022 ($ Millions)
Figure 27. APAC Human Rabies Immune Globulin (HRIG) Sales 2017-2022 (K Units)
Figure 28. APAC Human Rabies Immune Globulin (HRIG) Revenue 2017-2022 ($ Millions)
Figure 29. Europe Human Rabies Immune Globulin (HRIG) Sales 2017-2022 (K Units)
Figure 30. Europe Human Rabies Immune Globulin (HRIG) Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Human Rabies Immune Globulin (HRIG) Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Human Rabies Immune Globulin (HRIG) Revenue 2017-2022 ($ Millions)
Figure 33. Americas Human Rabies Immune Globulin (HRIG) Sales Market Share by Country in 2021
Figure 34. Americas Human Rabies Immune Globulin (HRIG) Revenue Market Share by Country in 2021
Figure 35. United States Human Rabies Immune Globulin (HRIG) Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Human Rabies Immune Globulin (HRIG) Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Human Rabies Immune Globulin (HRIG) Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Human Rabies Immune Globulin (HRIG) Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Human Rabies Immune Globulin (HRIG) Sales Market Share by Region in 2021
Figure 40. APAC Human Rabies Immune Globulin (HRIG) Revenue Market Share by Regions in 2021
Figure 41. China Human Rabies Immune Globulin (HRIG) Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Human Rabies Immune Globulin (HRIG) Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Human Rabies Immune Globulin (HRIG) Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Human Rabies Immune Globulin (HRIG) Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Human Rabies Immune Globulin (HRIG) Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Human Rabies Immune Globulin (HRIG) Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Human Rabies Immune Globulin (HRIG) Sales Market Share by Country in 2021
Figure 48. Europe Human Rabies Immune Globulin (HRIG) Revenue Market Share by Country in 2021
Figure 49. Germany Human Rabies Immune Globulin (HRIG) Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Human Rabies Immune Globulin (HRIG) Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Human Rabies Immune Globulin (HRIG) Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Human Rabies Immune Globulin (HRIG) Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Human Rabies Immune Globulin (HRIG) Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Human Rabies Immune Globulin (HRIG) Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Human Rabies Immune Globulin (HRIG) Revenue Market Share by Country in 2021
Figure 56. Egypt Human Rabies Immune Globulin (HRIG) Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Human Rabies Immune Globulin (HRIG) Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Human Rabies Immune Globulin (HRIG) Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Human Rabies Immune Globulin (HRIG) Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Human Rabies Immune Globulin (HRIG) Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Human Rabies Immune Globulin (HRIG) in 2021
Figure 62. Manufacturing Process Analysis of Human Rabies Immune Globulin (HRIG)
Figure 63. Industry Chain Structure of Human Rabies Immune Globulin (HRIG)
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...